NKTR

Nektar Therapeutics News Headlines

$10.91
*  
0.07
0.64%
Get NKTR Alerts
*Delayed - data as of Jul. 28, 2014  -  Find a broker to begin trading NKTR now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Sector Update: Healthcare
9/27/2013 8:30:23 AM - MT Newswires

Traders stick with Nektar Therapeutics
8/30/2013 4:34:16 AM - optionMONSTER

Market Wrap For Monday, August 12: Stocks Close Mixed To Start Week
8/12/2013 4:42:14 PM - Benzinga

Narrower-than-Expected Loss at Nektar - Analyst Blog
8/12/2013 11:25:01 AM - Zacks.com

Bulls pile into Nektar Therapeutics
8/2/2013 6:06:45 AM - optionMONSTER

Pipeline Progress at Nektar - Analyst Blog
7/31/2013 3:20:01 PM - Zacks.com

A Small Step For Nektar Therapeutics, A Giant Leap For The Fight Against Prescription Drug Abuse
6/21/2013 1:08:00 PM - Seeking Alpha

Nektar's Pain Drug Impresses - Analyst Blog
6/20/2013 5:20:01 PM - Zacks.com

Healthcare Stocks in Late Retreat; Nektar Therapeutics Reports Progress With Addiction Treatment
6/19/2013 3:41:47 PM - MT Newswires

Sector Update: Healthcare
6/19/2013 3:33:04 PM - MT Newswires

Mid-Day Market Update: La-Z-Boy Drops On Q4 Results, Nektar Gains
6/19/2013 12:32:56 PM - Benzinga

Upside position adjusted in Nektar
6/19/2013 5:29:18 AM - optionMONSTER

Nektar Presents Data on Oncology Candidates - Analyst Blog
6/5/2013 5:30:26 PM - Zacks.com

Data on AstraZeneca's Naloxegol - Analyst Blog
5/23/2013 6:28:59 PM - Zacks.com

After Hours Most Active for May 23, 2013 : DF, DF$, PFE, WWAV$, KWK, KSU, NKTR, INTC, QQQ, SYMC, SIRI, CSCO
5/23/2013 4:43:18 PM - NASDAQ.com News

Nektar Posts Wider Loss, Maintains View - Analyst Blog
5/15/2013 12:26:01 PM - Zacks.com

Positive Data on Nektar's NKTR-214 - Analyst Blog
4/8/2013 6:08:18 PM - Zacks.com

Several Big Growth Stories In Biotech: Keith Markey
3/28/2013 8:13:00 PM - Seeking Alpha

Why AstraZeneca Will Disappoint In 2013
3/17/2013 4:29:00 PM - Seeking Alpha

Nektar Loss Widens, Gives Guidance - Analyst Blog
3/7/2013 1:41:01 PM - Zacks.com

AZN Reports Naloxegol Safety Data - Analyst Blog
2/27/2013 5:28:46 PM - Zacks.com

4 Drug Delivery Companies That Deliver For Investors
2/27/2013 4:21:00 PM - Seeking Alpha

Synergy Targets Root Cause Of Irritable Bowel Syndrome
2/24/2013 6:11:00 AM - Seeking Alpha

Is Zogenix A Buy After FDA Panel Says 'No' To Zohydro?
12/14/2012 1:50:00 PM - Seeking Alpha

Alexza's Adasuve May Not Be Ready For FDA Approval
12/11/2012 3:47:00 PM - Seeking Alpha